ATS 2017 International Conference - Mobile

603 The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Anti-Tussive Therapy for Chronic Refractory Cough: Results from a Phase 2 Study (VOLCANO-1)

Sunday

May

21

2:15 PM

4:15 PM

Type : Scientific Abstract

Speaker(s)

Jaclyn A. Smith

David Allman

Huda Badri

Robert Miller

Julie Morris

Imran Satia

Andrew Wood

Michael Trower

Content

Parent Sessions

A101 ADVANCES IN COUGH, DYSPNEA, AND INTERVENTIONAL PULMONARY...
05-21-2017 2:15 PM - 4:15 PM